tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Keith Markey, 14 are a BUY (87.5%), 1 are a HOLD (6.25%), 1 are a SELL (6.25%).
Analyst Keith Markey, carries an average stock price target met ratio of 47.5% that have a potential upside of 48.76% achieved within 243 days. Previously, Keith Markey worked at GUGGENHEIM, EVERCORE, GRIFFIN SECURITIES.
Keith Markey’s has documented 31 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on PGEN, Precigen at 06-Jun-2016.
Analyst best performing recommendations are on TCRT (ALAUNOS THERAPEUTICS).
The best stock recommendation documented was for TCRT (ALAUNOS THERAPEUTICS) at 1/14/2015. The price target of $1800 was fulfilled within 48 days with a profit of $469.5 (35.29%) receiving and performance score of 7.35.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 04-Oct-2017
$27
$24.28 (892.65%)
6 years 11 months 11 days ago
(13-Nov-2019)
0/3 (0%)
$21.53 (393.60%)
Buy Since 19-Oct-2015
$50
7 years 7 months 23 days ago
(01-Mar-2019)
1/3 (33.33%)
$16.58 (49.61%)
37
Buy Since 10-Nov-2015
$57
$54.28 (1995.59%)
$69
10 years 7 months 23 days ago
(01-Mar-2016)
0/3 (0%)
$23.59 (70.61%)
Hold Since 10-Nov-2015
$28
10 years 7 months 23 days ago
(01-Mar-2016)
1/2 (50%)
$1.52 (5.74%)
3
Buy Since 23-Feb-2015
$65
$62.28 (2289.71%)
$65
10 years 8 months 26 days ago
(28-Jan-2016)
2/4 (50%)
$36.28 (126.32%)
146
